Madrigal Pharmaceuticals's total assets for Q2 2025 were $1.02B, an increase of 1.88% from the previous quarter. MDGL total liabilities were $319.40M for the fiscal quarter, a 11.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.